Longevity Biotechnology companies

Emerald Bioventures was formed to incubate and build transformational life sciences companies with extraordinary entrepreneurs. Based on cutting-edge science, m…

K2HV’s investment professionals bring together substantial experience across multiple verticals in healthcare finance and operations, as well as considerable sc…

Global Health X (GHX) is a Healthcare and Life Sciences Venture studio, accelerator and fund, serving as the Innovation and R&D arm of the Global University…

A force multiplier for scientists and innovators pushing the boundaries of what’s possible in biology and beyond. We are a team of biologists, engineers, and re…

We are an investment firm with more than 25 years of experience backing transformational healthcare and biotech companies. We see the world through an entrepren…

We strive to invest in companies that develop innovative drugs, medical devices and diagnostics. We focus on generating strong financial returns from our portfo…

Our expertise in biopharma and biotech investments. With decades of experience and a robust network within the biopharma and biotech industries, our team offers…

Curie.Bio is a unique combination of two businesses: we act as both your drug discovery copilot & seed investor. We have some of the world’s best drug hunte…

We invest in deep tech startups with exceptional founders and breakthrough technologies that offer solutions for a sustainable tomorrow. As core technologies, b…

Bioluminescence Ventures is a biotechnology venture firm investing in Drug Discovery Platforms (Oncology, Immunology, Neuroscience, Genetic Diseases), Applied B…

We are Lumira Ventures. $450M+ Invested: Over more than two decades, our firm has invested over $1B via multiple investment funds. $70B+ Cumulative Revenue of P…

Our business is to turn scientists into entrepreneurs who can save lives and save the planet (we call this “human and planetary health”). Personal, 1 on 1, with…

AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe. AdBio partners’ uniq…

Mirae Asset Capital Life Science was formed in 2023 as a joint venture between Mirae Asset Capital and Mirae Asset Global Investments. It is the first and only…

The myeloma patient community has no time for business as usual. Multiple myeloma is a highly heterogenous bone marrow cancer that requires a multitude of drugs…

82VS is our affiliated venture studio that pairs Alloy’s platforms and services with a team of company creation experts to efficiently launch new asset-centric…

Since 2001, St. Louis nonprofit BioSTL has laid the foundation for the region's​ innovation economy with a comprehensive set of transformational programs that a…

We are in the midst of the greatest period of innovation civilisation has ever seen. This century, technology will revolutionise our lives more powerfully and m…

We’re not just an investor. We’re all about being an active stakeholder. Identify: We are renown for identifying early stage technologies and start-ups. Our est…

We are the global leader in the search for a cure for cystic fibrosis and nearly every CF drug and therapy available today was made possible because of CF Found…